Menlo Therapeutics #IPO Preview $MNLO
Company: Menlo Therapeutics, Inc. Symbol: MNLO Description: They are a late‑stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. Shares: 5.67 million Price Range: $14.00-$16.00 Trade Date: 1/25 Underwriter(s): Jefferies, Piper Jaffray, Guggenheim Securities[…]
